Pure Bioscience (PURE)
OTHER OTC:PURE

Pure Bioscience (PURE) Financial Statements

40 Followers

Pure Bioscience Financial Overview

Pure Bioscience's market cap is currently ―. The company's EPS TTM is $-0.032; its P/E ratio is -2.22; Pure Bioscience is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Apr 23Jan 23
Income Statement-
Total Revenue$ 441.00K$ 326.00K$ 722.00K$ 406.00K$ 397.00K
Gross Profit$ 258.00K$ 177.00K$ 442.00K$ 196.00K$ 197.00K
EBIT$ -816.00K$ -964.00K$ -711.00K$ 1.69M$ -1.06M
EBITDA$ -780.00K$ -927.00K$ -674.00K$ 1.73M$ -1.02M
Net Income Common Stockholders$ -857.00K$ -1.00M$ -735.00K$ 1.69M$ -1.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 442.00K$ 557.00K$ 1.44M$ 856.00K$ 1.56M
Total Assets$ 920.00K$ 1.09M$ 2.25M$ 1.82M$ 2.53M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -442.00K$ -557.00K$ -1.44M$ -856.00K$ -1.56M
Total Liabilities$ 666.00K$ 2.41M$ 2.63M$ 569.00K$ 463.00K
Stockholders Equity$ -2.15M$ -1.32M$ -383.00K$ 1.25M$ 2.07M
Cash Flow-
Free Cash Flow$ -615.00K$ -883.00K$ -440.00K$ -704.00K$ -967.00K
Operating Cash Flow$ -615.00K$ -883.00K$ -440.00K$ -665.00K$ -967.00K
Investing Cash Flow---$ -39.00K-
Financing Cash Flow$ 500.00K-$ 785.00K--
Currency in USD

Pure Bioscience Earnings and Revenue History

Pure Bioscience Debt to Assets

Pure Bioscience Cash Flow

Pure Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis